Skip to main content
Fig. 3 | BMC Public Health

Fig. 3

From: Systematic literature review of the impact and effectiveness of monovalent meningococcal C conjugated vaccines when used in routine immunization programs

Fig. 3

a Impact of MCCV program in Spain, different age groups (Incidence rate reduction comparing pre-and-post-vaccination periods). Cano*: Cano 2004; Martinez#: Martinez 2009; Rojo¤: Rojo 2005. MCCV program introduced in the NIP in 2000 (2, 4, 6 months of age). Subsequent schedule changes were made in 2006 (at 2, 4–6, 12–24 months), 2014 (at 2, 4–6, 12–24 months, 12 years). b Impact of MCCV program in Spain, all ages (Incidence rate reduction comparing pre-and-post-vaccination periods). MCCV program introduced in the NIP in 2000 (at 2,4, 6 months of age). Subsequent schedule changes were made in 2006 (at 2, 4–6, 12–24 months), 2014 (at 2, 4–6, 12–24 months, 12 years)

Back to article page

BMC Public Health

ISSN: 1471-2458

Contact us